Group-based Peer Support Versus Individual Education for Patients Undergoing CPAP Treatment
20. marts 2019 opdateret af: Susan Redline, Brigham and Women's Hospital
The investigators will compare two alternatives designed to maximize adherence to continuous positive airway pressure (CPAP) therapy for obstructive sleep apnea (OSA) - peer-support administered in groups, versus individual education.
Studieoversigt
Status
Afsluttet
Betingelser
Intervention / Behandling
Detaljeret beskrivelse
The study is a 6-week, open-label, parallel-arm, randomized controlled trial comparing peer support and individual education (the latter of which was designed to mimic usual care).
Participants in the peer-support (intervention) arm will be encouraged to attend two peer-support sessions, with one session occurring immediately prior to beginning CPAP and the other occurring two weeks later.
Participants in the individual education (comparator) arm will begin CPAP without attendance at any peer-support sessions.
Undersøgelsestype
Interventionel
Tilmelding (Faktiske)
40
Fase
- Ikke anvendelig
Kontakter og lokationer
Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.
Studiesteder
-
-
Massachusetts
-
Boston, Massachusetts, Forenede Stater, 02115
- Brigham and Women's Hospital
-
-
Deltagelseskriterier
Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.
Berettigelseskriterier
Aldre berettiget til at studere
21 år og ældre (Voksen, Ældre voksen)
Tager imod sunde frivillige
Ingen
Køn, der er berettiget til at studere
Alle
Beskrivelse
Inclusion Criteria:
- Diagnosed with obstructive sleep apnea (no cut-off for severity)
- Prescribed continuous positive airway pressure
Exclusion Criteria:
- Not fluent in English
- Prior CPAP use at home
- Current use of any non-CPAP treatment for obstructive sleep apnea
- A co-morbid sleep disorder
- Use of supplemental oxygen
- A clinical need for urgent CPAP therapy
Studieplan
Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Støttende pleje
- Tildeling: Randomiseret
- Interventionel model: Parallel tildeling
- Maskning: Ingen (Åben etiket)
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
|---|---|
|
Aktiv komparator: CPAP + Peer Support
Participants randomized to this arm will receive support from a 'CPAP Peer Leader', delivered as part of a group of other participants as well as targeted one-on-one support throughout the study. All participants will receive CPAP in addition to this intervention. |
|
|
Aktiv komparator: CPAP + Individual Education
Participants randomized to this arm will receive individual support and education from a trained investigator. All participants will receive CPAP in addition to this intervention. |
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Adherence
Tidsramme: 6 weeks
|
Objective adherence to CPAP, measured in hours per night.
|
6 weeks
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Percentage of Participants With Adherence >=4 Hours/Night on Average
Tidsramme: 6 weeks
|
Objective adherence to CPAP, percentage with adherence >=4 hours/night on average
|
6 weeks
|
|
FOSQ
Tidsramme: 6 weeks
|
Functional Outcomes of Sleep Questionnaire.
The FOSQ is a questionnaire which allows the participant to describe their sleep quality, on a scale of 5 to 20.
Higher scores indicate better sleep.
|
6 weeks
|
|
SEMSA - Perceived Risk
Tidsramme: 6 weeks
|
Self Efficacy Measure for Sleep Apnea - Perceived Risk The SEMSA contains three sub-scales, each scored on a scale of 1 to 4. A higher score indicates a higher degree of perceived risk associated with sleep apnea.
|
6 weeks
|
|
SEMSA - Outcome Expectations
Tidsramme: 6 weeks
|
Self Efficacy Measure for Sleep Apnea - Outcome Expectations.
The SEMSA contains three sub-scales, each scored on a scale of 1 to 4. A higher score indicates a higher degree of outcome expectations associated with treatment of sleep apnea.
|
6 weeks
|
|
SEMSA - Self Efficacy
Tidsramme: 6 weeks
|
Self Efficacy Measure for Sleep Apnea - Self Efficacy The SEMSA contains three sub-scales, each scored on a scale of 1 to 4. A higher score indicates a higher degree of self efficacy associated with treatment of sleep apnea.
|
6 weeks
|
Samarbejdspartnere og efterforskere
Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.
Sponsor
Efterforskere
- Ledende efterforsker: Susan Redline, MD, Brigham and Women's Hospital
Datoer for undersøgelser
Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.
Studer store datoer
Studiestart
1. oktober 2015
Primær færdiggørelse (Faktiske)
1. september 2016
Studieafslutning (Faktiske)
1. september 2016
Datoer for studieregistrering
Først indsendt
31. august 2015
Først indsendt, der opfyldte QC-kriterier
31. august 2015
Først opslået (Skøn)
2. september 2015
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
21. marts 2019
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
20. marts 2019
Sidst verificeret
1. marts 2019
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- 2014P002326
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .